Network origin in Gerrard McKenna first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Nippon Boehringer Ingelheim Co., Ltd.
 Nippon Boehringer Ingelheim Co., Ltd. Pharmaceuticals: MajorHealth Technology Established in 1961, Nippon Boehringer Ingelheim Co., Ltd. develops, manufactures, imports and markets pharmaceutical products. The company is also involved in the importation and exportation of intermediates and bulk pharmaceutical products. Nippon Boehringer Ingelheim is based in Tokyo and operates in several parts of Japan through its domestic offices.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Gerrard McKenna via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SSP Co., Ltd.
 SSP Co., Ltd. Pharmaceuticals: MajorHealth Technology SSP Co., Ltd. engages in the manufacture and sale of pharmaceuticals, quasi-drugs and cosmetics. The company was founded in 1765 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member | |
UB4/BB GmbH & Co. KG
 UB4/BB GmbH & Co. KG Financial ConglomeratesFinance UB4/BB GmbH & Co. KG provides financial services. The private company is based in Ingelheim am Rhein, Germany. The German company was founded in 2001. The CEO is Christoph Gauger. | Financial Conglomerates | Chief Executive Officer | |
Novartis Pharma KK
 Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Novartis Pharma KK develops, imports, produces and sells pharmaceutical products. The company was founded on April 1, 1997 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member | |
Boehringer Ingelheim Japan Investment GK
 Boehringer Ingelheim Japan Investment GK Financial ConglomeratesFinance Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Japan Investment GK is an investment holding Japanese company. The company is based in Tokyo, Japan. | Financial Conglomerates | President | |
Boehringer Ingelheim Stiftung GmbH
 Boehringer Ingelheim Stiftung GmbH Investment Trusts/Mutual FundsMiscellaneous Boehringer Ingelheim Stiftung GmbH is a German company that engages in promoting scientific research and development. The private company is based in Ingelheim am Rhein, Germany. The company was founded in 1992. The CEO is Christoph Gauger. | Investment Trusts/Mutual Funds | Chief Executive Officer |
Statistics
International
| Germany | 4 |
| Japan | 4 |
| United States | 2 |
Sectoral
| Health Technology | 5 |
| Finance | 3 |
| Miscellaneous | 2 |
Operational
| Director/Board Member | 6 |
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 1 |
| Comptroller/Controller/Auditor | 1 |
| Chief Administrative Officer | 1 |
Most connected contacts
| Insiders | |
|---|---|
| Christoph Gauger | 7 |
| Masao Torii | 2 |
| Yoshiki Nishikawa | 1 |
| Thomas Kuerner | 1 |
| Gerhard Koeller | 1 |
- Stock Market
- Insiders
- Gerrard McKenna
- Company connections
